The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 140,386 | 9,817,190 | SH | DFND | 1 | 9,817,190 | 0 | 0 | |
| AURORA ACQUISITION CORP | CLASS A ORD SHS | G0698L103 | 26,730 | 2,700,000 | SH | DFND | 1 | 2,700,000 | 0 | 0 | |
| AURORA ACQUISITION CORP | *W EXP 03/02/202 | G0698L129 | 520 | 675,000 | SH | Call | DFND | 1 | 675,000 | 0 | 0 |
| BLUE WHALE ACQUISITION CORP | CLASS A ORD SHS | G1330M103 | 9,681 | 998,000 | SH | DFND | 1 | 998,000 | 0 | 0 | |
| BLUE WHALE ACQUISITION CORP | *W EXP 07/30/202 | G1330M129 | 212 | 249,500 | SH | Call | DFND | 1 | 249,500 | 0 | 0 |
| COMPUTE HEALTH ACQUISITIN CO | COM CL A | 204833107 | 38,920 | 4,000,000 | SH | DFND | 1 | 4,000,000 | 0 | 0 | |
| COMPUTE HEALTH ACQUISITIN CO | *W EXP 01/25/202 | 204833115 | 883 | 1,000,000 | SH | Call | DFND | 1 | 1,000,000 | 0 | 0 |
| ELLIOTT OPPORTUNITY II CORP | *W EXP 03/02/202 | G30092111 | 1,324 | 1,237,500 | SH | Call | DFND | 1 | 1,237,500 | 0 | 0 |
| EQRX INC | COM | 26886C107 | 294,464 | 43,176,600 | SH | DFND | 1 | 43,176,600 | 0 | 0 | |
| EQRX INC | *W EXP 12/17/202 | 26886C115 | 852 | 800,000 | SH | Call | DFND | 1 | 800,000 | 0 | 0 |
| FTAC ATHENA ACQUISITION CORP | *W EXP 03/01/202 | G37283119 | 575 | 500,000 | SH | Call | DFND | 1 | 500,000 | 0 | 0 |
| FTAC HERA ACQUISITION CORP | *W EXP 02/28/202 | G3728Y111 | 1,187 | 1,250,000 | SH | Call | DFND | 1 | 1,250,000 | 0 | 0 |
| LEARN CW INVESTMENT COR | UNIT 99/99/9999 | G54157121 | 101,200 | 10,000,000 | SH | DFND | 1 | 10,000,000 | 0 | 0 | |
| LYELL IMMUNOPHARMA INC | COM | 55083R104 | 27,090 | 3,500,000 | SH | DFND | 1 | 3,500,000 | 0 | 0 | |
| NERDY INC | CL A COM | 64081V109 | 743 | 165,000 | SH | DFND | 1 | 165,000 | 0 | 0 | |
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 166,874 | 8,156,107 | SH | DFND | 1 | 8,156,107 | 0 | 0 | |
| PIONEER MERGER CORP | *W EXP 01/07/202 | G7S24C111 | 595 | 916,666 | SH | Call | DFND | 1 | 916,666 | 0 | 0 |
| REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 29,220 | 3,000,000 | SH | DFND | 1 | 3,000,000 | 0 | 0 | |
| REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 450 | 600,000 | SH | Call | DFND | 1 | 600,000 | 0 | 0 |
| SANA BIOTECHNOLOGY INC | COM | 799566104 | 34,195 | 2,209,004 | SH | DFND | 1 | 2,209,004 | 0 | 0 | |
| SCVX CORP | *W EXP 01/24/202 | G79448117 | 170 | 500,000 | SH | Call | DFND | 1 | 500,000 | 0 | 0 |
| SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 40,236 | 9,021,524 | SH | DFND | 1 | 9,021,524 | 0 | 0 | |
| SIGNA SPORTS UNITED NV | ORD SHS | N80029106 | 42,400 | 5,000,000 | SH | DFND | 1 | 5,000,000 | 0 | 0 | |
| SVF INVESTMENT CORP | UNIT 12/20/2025 | G8601L110 | 22,616 | 2,200,000 | SH | DFND | 1 | 2,200,000 | 0 | 0 | |
| SVF INVESTMENT CORP 2 | CL A SHS | G8601M100 | 9,900 | 1,000,000 | SH | DFND | 1 | 1,000,000 | 0 | 0 | |
| SVF INVESTMENT CORP 3 | CL A SHS | G8601N108 | 20,000 | 2,000,000 | SH | DFND | 1 | 2,000,000 | 0 | 0 | |